Gene · 3672
Papers3,336
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,336
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tendon tissue engineering: An overview of biologics to promote tendon healing and repair. | J Tissue Eng | 2023 | 37719308 | PubTator, text mining | PubMed |
| Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma. | NPJ Precis Oncol | 2023 | 37717087 | PubTator, text mining | PubMed |
| Unlocking the post-transplant microenvironment for successful islet function and survival. | Front Endocrinol (Lausanne) | 2023 | 37711891 | PubTator, text mining | PubMed |
| Characteristics and sources of tissue-resident memory T cells in psoriasis relapse. | Curr Res Immunol | 2023 | 37701270 | PubTator, text mining | PubMed |
| Lymphatic vessel transit seeds precursors to cytotoxic resident memory T cells in skin draining lymph nodes. | bioRxiv | 2023 | 37693469 | PubTator, text mining | PubMed |
| Does molecular scarring in psoriasis exist? A review of the literature. | Postepy Dermatol Alergol | 2023 | 37692280 | PubTator, text mining | PubMed |
| Tissue-resident and innate-like T cells in patients with advanced chronic liver disease. | JHEP Rep | 2023 | 37691689 | PubTator, text mining | PubMed |
| THBS1-Mediated Degradation of Collagen via the PI3K/AKT Pathway Facilitates the Metastasis and Poor Prognosis of OSCC. | Int J Mol Sci | 2023 | 37686118 | PubTator, text mining | PubMed |
| Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer. | Sci Immunol | 2023 | 37683037 | PubTator, text mining | PubMed |
| Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations. | Cell Death Dis | 2023 | 37673877 | PubTator, text mining | PubMed |
| Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and future. | Front Pharmacol | 2023 | 37670950 | PubTator, text mining | PubMed |
| Memory T Cells in the Immunoprevention of Cancer: A Switch from Therapeutic to Prophylactic Approaches. | J Immunol | 2023 | 37669503 | PubTator, text mining | PubMed |
| Analysis of matrisome expression patterns in murine and human dorsal root ganglia. | Front Mol Neurosci | 2023 | 37664243 | PubTator, text mining | PubMed |
| Feet and legs malformation in Nellore cattle: genetic analysis and prioritization of GWAS results. | Front Genet | 2023 | 37662838 | PubTator, text mining | PubMed |
| Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors. | J Clin Invest | 2023 | 37655659 | PubTator, text mining | PubMed |
| Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment. | Front Immunol | 2023 | 37654492 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of human non-hematopoietic bone marrow cells reveals a unique set of inter-species conserved biomarkers for native mesenchymal stromal cells. | Stem Cell Res Ther | 2023 | 37649081 | PubTator, text mining | PubMed |
| Quantitative proteomic and phosphoproteomic analysis reveal the relationship between mitochondrial dysfunction and cytoskeletal remodeling in hiPSC-CMs deficient in PINK1. | J Transl Med | 2023 | 37649075 | PubTator, text mining | PubMed |
| Trophoblast Differentiation: Mechanisms and Implications for Pregnancy Complications. | Nutrients | 2023 | 37630754 | PubTator, text mining | PubMed |
| Epithelial Galectin-3 Induced the Mitochondrial Complex Inhibition and Cell Cycle Arrest of CD8+ T Cells in Severe/Critical COVID-19. | Int J Mol Sci | 2023 | 37628961 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3672/papers?page=16